Aspire Private Capital’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-8
| Closed | -$45 | – | 716 |
|
|
2023
Q2 | $45 | Hold |
8
| – | – | ﹤0.01% | 669 |
|
|
2023
Q1 | $82 | Hold |
8
| – | – | ﹤0.01% | 645 |
|
|
2022
Q4 | $156 | Hold |
8
| – | – | ﹤0.01% | 630 |
|
|
2022
Q3 | $0 | Hold |
8
| – | – | ﹤0.01% | 638 |
|
|
2022
Q2 | $0 | Hold |
8
| – | – | ﹤0.01% | 623 |
|
|
2022
Q1 | $0 | Hold |
8
| – | – | ﹤0.01% | 635 |
|
|
2021
Q4 | $0 | Hold |
8
| – | – | ﹤0.01% | 655 |
|
|
2021
Q3 | $1K | Buy |
+8
| New | +$1K | ﹤0.01% | 550 |
|
|
2021
Q1 | – | Sell |
-8
| Closed | -$1K | – | 570 |
|
|
2020
Q4 | $1K | Hold |
8
| – | – | ﹤0.01% | 421 |
|
|
2020
Q3 | $1K | Buy |
+8
| New | +$1K | ﹤0.01% | 424 |
|
|
2020
Q1 | – | Sell |
-8
| Closed | – | – | 370 |
|
|
2019
Q4 | $0 | Hold |
8
| – | – | ﹤0.01% | 516 |
|
|
2019
Q3 | $0 | Hold |
8
| – | – | ﹤0.01% | 502 |
|
|
2019
Q2 | $0 | Hold |
8
| – | – | ﹤0.01% | 577 |
|
|
2019
Q1 | $0 | Hold |
8
| – | – | ﹤0.01% | 591 |
|
|
2018
Q4 | $0 | Buy |
+8
| New | – | ﹤0.01% | 559 |
|